Allogeneic peripheral blood stem cell transplantation for standard risk leukemia: Experience of Ibni Sina Hospital

Bone Marrow Transplantation

Volumn 25, Issue 12, 2000, Pages 1229-1232

  Arslan, O ^a   Coskun H S ^a   Arat, M ^a   Celebi H ^a   Ozcan M ^a   Gurman G ^a   Ustun C ^a   Demirer, T ^a   Akan, H ^a   Ilhan, O ^a   Konuk, N ^a   Beksac M ^a   Uysal, A ^a   Koc H ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Allogeneic peripheral blood stem cell transplantation; Graft versus host disease; Standard risk leukemia

Indexed keywords

CYCLOSPORIN A; GRANULOCYTE COLONY STIMULATING FACTOR; METHOTREXATE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOTRANSPLANTATION; ARTICLE; DISEASE SEVERITY; FEMALE; GRAFT VERSUS HOST REACTION; GRANULOCYTE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; SIBLING; SURVIVAL RATE; THROMBOCYTE COUNT; TURKEY (REPUBLIC);

EID: 0342646987     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702414     Document Type: Article

References (21)

1. Kessinger A, Smith DM, Strandjord SE et al. Allogeneic transplantation of blood-derived, T cell-depleted hematopoietic stem cells after myeloablative treatment in a patient with acute lymphoblastic leukemia. Bone Marrow Transplant 1989; 4: 643-646.
2. Russell NH, Hunter A, Rogers S et al. Peripheral blood stem cells as an alternative to marrow for allogeneic transplantation (letter). Lancet 1993; 341; 1482-1493.
3. Dreger P, Haferlach T, Eckstein V et al. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft. Br J Haematol 1994; 87: 609-613.
4. Tjønnfjord GE, Steen R, Evensen SA et al. Characterization of CD34+ peripheral blood cells from healthy adults mobilized by recombinant human granulocyte colony-stimulating factor. Blood 1994; 84: 2795-2801.
5. Bensinger WI, Price TH, Dale DC. The effects of daily recombinant human granulocyte colony stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood 1993; 81: 1883-1888.
6. Bensinger WI, Weaver CH, Applebaum FR et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony stimulating factor. Blood 1995; 85: 1655-16.58.
7. Schmitz N, Dreger P, Suttorp M et al. Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by Filgrastim (G-CSF). Blood 1995; 85: 1666-1672.
8. Körbling M, Przepiorka D, Huh YO et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood 1995; 85: 1659-1665.
9. Bensinger WI, Clift R, Martin P et al. Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation. Blood 1996; 88: 2794-2800.
10. Hoglund H, Ringden O, Remberger M et al. Faster neutrophil and platelet engraftment, but no differences in acute GVHD or survival, using blood stem cells from related and unrelated donors, compared to bone marrow. Bone Marrow Transplant 1998; 22: 131-136.
11. Üstiin C, Arslan Ö, Beksaç M et al. A retrospective comparison of allogeneic peripheral blood stem cell and bone marrow transplantation results from a single center, a focus on the incidence of GVHD and relapse. Biol Blood Marrow Transplant 1999; 5: 28-35.
12. Bensinger WI, Clift RA, Anasetti C et al. Transplantation of allogeneic peripheral stem cells mobilized by recombinant human granulocyte colony stimulating factor. Stem Cells 1995; 14: 90-105.
13. Koç H, Gürman G, Arslan Ö et al. Is there an increased risk of graft versus host disease after allogeneic peripheral blood stem cell transplantation. Blood 1996; 88: 2362-2364.
14. Urbano-Ispizua A, Garcia-Conde J, Brunet S et al. High incidence of chronic graft versus host disease (GVHD) after allogeneic peripheral blood progenitor cell transplantation (alloPBPCT) from matched related donors. Blood 1996; 88 (Suppl. 1): 617 (Abstr. 2455).
15. Garcia-Conde J, Martin-Gaitero MJ, Arbona C et al. High frequency of chronic graft versus host disease (GVHD) associated with unmodified allogeneic peripheral blood progenitor cell transplantation (alloPBPCT). Preliminary results of allogeneic CD34+ selected cell PBPCT. Blood 1996; 88 (Suppl. 1): 261 (Abstr. 1031).
16. Majolino I, Scime R, Cavallaro AM et al. Allogeneic PBSC transplantation: report from the Palermo Center. Blood 1996; 88 (Suppl. 1): 276 (Abstr. 3830).
17. Azevedo AM, Correa MEP, Vigorito AC et al. Chronic graft versus host disease after allogeneic transplants with peripheral blood stem cells or bone marrow: a comparative study. Blood 1996; 88 (Suppl. 1): 273 (Abstr. 3818).
18. Goldman JM, Schmitz N, Niethammer D et al for the Accreditation Sub-Committee of the European Group for Blood and Marrow Transplantation. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe in 1998. Bone Marrow Transplant 1998; 21, 1-7.
19. Storek J, Gooley T, Siadak M et al. Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus host disease. Blood 1997; 90: 4705-4709.
20. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
21. Arslan Ö, Üstün C, Arat M et al. Allogeneic peripheral stem cell transplantation in acute nonlymphoblastic leukemia. Hematol Oncol 1998; 16: 155-162.